Big Gain For Immunic, Inc.
Tue, Oct 11, 2022 at 07:52 PM
Immunic, Inc. (IMUX:NASDAQ) rocketted at $9.41, a gain of 51.8%. On Tue, Oct 11, 2022, IMUX:NASDAQ hit a New 2-Week High of $9.41. The stock appeared on our News Catalysts scanner on Mon, Oct 10, 2022 at 07:33 AM in the 'PRIVATE PLACEMENT' category. From Tue, Sep 27, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days
About Immunic, Inc. (IMUX:NASDAQ)
Vital Therapies Inc is a biotherapeutic company. It is involved in the business of developing liver treatment to improve survival in patients with Liver failure by providing hepatic support continuously for up to five days. The firm's main product candidate is ELAD system. It also owns VTL C3A cell bank which supports ELAD system.
Top 10 Gainers:
- FedNat Holding Company (FNHC:NASDAQ), 107.65%
- DICE Therapeutics Inc. (DICE:NASDAQ), 62.27%
- Immunic, Inc. (IMUX:NASDAQ), 51.77%
- ForgeRock Inc. Class A (FORG:NYSE), 48.55%
- Laser Photonics Corporation (LASE:NASDAQ), 44.39%
- scPharmaceuticals Inc. (SCPH:NASDAQ), 39.3%
- Oblong Inc. (OBLG:NASDAQ), 38.63%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 35.27%
- Meiwu Technology Company Limited (WNW:NASDAQ), 33.74%
- Agrify Corporation (AGFY:NASDAQ), 32.62%